OpenAI is winning, making SoftBank stock worth seriously considering as an investment. The view is still at the consideration stage. x.com 

SoftBank stands to benefit as OpenAI's comeback plays out, with the general discourse already shifting this week. Codex revenue doubled in seven days, while Anthropic still needs to solve its compute situation, consistent with the call that GPT-5.5 and new Codex features would recapture share and OpenAI's earlier compute spending would sustain its lead. x.com 

SoftBank's $64.6 billion OpenAI commitment leaves it exposed to a loss-making company that needs more funding, while junk-rated borrowing costs around 10% and credit spreads have climbed. An OpenAI IPO matters greatly; despite SoftBank's good assets, a price roughly another 50% lower could look like value. x.com  x.com 

OpenAI's funding strain makes Oracle's AI revenue less dependable because OpenAI pays its bills with money it must keep raising. Investors resisted Morgan Stanley's $1.4 trillion valuation pitch, forcing a cut to $1.25 trillion, and the next raise could come in below $30 billion; contracts funded by fundraising are worth less than contracts funded by cash flow. x.com 

SoftBank Group may be due to catch up as its key holdings rally while its stock stays flat. Arm is up 23% since Friday, OpenAI is now set to go public in September, and SoftBank-backed SB Energy has filed to go public. Masayoshi Son could be on the mend, and it may be time to buy. x.com 

SoftBank's leveraged AI bets look increasingly stressed even with markets at highs supporting its leverage. Its five-year CDS reached 424 basis points, up 24 basis points on the day; the cited estimate puts five-year cumulative default probability at 29.8%, approaching the kind of strain seen in CoreWeave. x.com 

OpenAI's weakening fundraising makes CoreWeave's customer-backed demand less dependable because OpenAI pays its bills with money it must keep raising. Investors resisted Morgan Stanley's $1.4 trillion valuation pitch, and OpenAI cut its target to $1.25 trillion; it could raise less than $30 billion by October 30. A contract paid from fundraising is worth less than one paid from cash flow, even though the AI story is not over. x.com 

Diversified cash flows in the billions make the AI-buildout basket more appealing than standalone model companies. Many members look reasonably priced and have longer records of delivering returns; Anthropic and OpenAI look much more like gambles at current valuations, though either could appeal at the right price. A possible equal-weight portfolio to revisit in five years includes Amazon, Alphabet, Microsoft, Meta, Oracle and SpaceX. x.com  x.com 

SoftBank's 9% drop after Moonshot released Kimi K3 was warranted, because K3 erodes the pricing power behind the valuation of OpenAI, which SoftBank's stock tracks. K3 is slightly better than Opus 4.8 at roughly half the cost, leaving Moonshot only months behind the frontier, so the tier where most commercial workloads run may soon be served at commodity prices. Labs' defensible ground shrinks to the true frontier, enterprise trust and distribution, and revenue can grow while pricing erodes. … Show more

Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.com